Medistim ASA (OSL:MEDI) Net Change in Cash : kr18.3 Mil (TTM As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Medistim ASA Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Medistim ASA's Net Change in Cash for the three months ended in Mar. 2024 was kr16.4 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was kr18.3 Mil.

Medistim ASA Net Change in Cash Historical Data

The historical data trend for Medistim ASA's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medistim ASA Net Change in Cash Chart

Medistim ASA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

19.25

5.15

57.60

23.15

1.23

Medistim ASA Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Change in Cash	Get a 7-Day Free Trial															-3.37	-58.43	35.58	24.80	16.39

Medistim ASA Net Change in Cash Calculation

Medistim ASA's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	113.189	+	-29.726	+	-84.883	+	2.651
	=	1.2

Medistim ASA's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 22.118 + -3.63 + -2.096 + 0

= 16.4

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr18.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medistim ASA Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Medistim ASA's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Medistim ASA (OSL:MEDI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medistim ASA (OSL:MEDI) » Definitions » Net Change in Cash

Comparable Companies

OSL:GENT OSL:LIFE OSL:OBSRV ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA ALGN XSWX:SOON SHSE:688271 ASX:COH LSE:SN. PODD OCSE:DEMANT

Traded in Other Exchanges

MEDIO:Sweden MD1:Germany

Address

Okernveien 94, Oslo, NOR, 0579

Website

https://www.medistim.com

Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing and sales of medical equipment through its own business or through participation in other companies, as well related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, Asia and the Rest of the World. The firm's activity is split into three strategic operating units, Lease of equipment; Lease of equipment and Distribution and sales of third-party products.

Medistim ASA (OSL:MEDI) Headlines